What cbdMD does

cbdMD, Inc. (AMEX: YCBD) is a Charlotte, North Carolina-based, publicly traded consumer wellness company founded in 2015 that manufactures and sells hemp-derived cannabinoid products under the cbdMD, Bluebird Botanicals, and Herbal Oasis brands. Its core product portfolio spans broad-spectrum and full-spectrum CBD gummies, softgels, oil tinctures, topicals, pet products, and a Delta 9 THC line including nano-emulsified gummies, micro mints, drink mixers, and the Herbal Oasis THC-infused social seltzer. Technical differentiators include nano-emulsion technology for bioavailability and a proprietary scientific platform comprising published OECD-standard preclinical toxicology data, human randomized controlled trial evidence, and GRAS regulatory status that the company positions as unmatched within the hemp-derived CBD category.

The business operates a hybrid go-to-market model. The primary engine is direct-to-consumer e-commerce at cbdMD.com with a Subscribe & Save subscription program offering 25–35% discounts and free priority shipping, complemented by a global wholesale/bulk B2B program for retailers and resellers. Regional distribution partnerships — notably Morales Beverage Group for Herbal Oasis in Louisiana and the Gulf South — extend the beverage line. In April 2026 the company launched a clinical healthcare channel, leveraging CMS guidance activating the Substance Access Beneficiary Engagement Incentive (BEI) to position cbdMD as the first federally enabled hemp-derived CBD supplier in the Medicare channel serving physicians, ACO REACH participants, and Enhancing Oncology Model practices.

Revenue mechanics span one-time purchases, recurring subscriptions, wholesale bulk transactions, and emerging enterprise clinical sales. Recent corporate actions include the January 2026 acquisition of Gaia Botanicals' assets (including the Bluebird Botanicals brand and online marketplace) via an all-equity transaction, a $2.25M preferred financing from C/M Capital Master Fund, a Charlotte lease restructuring that reduces gross rent by approximately $450K annually, and a shareholder-authorized reverse stock split. The company employs 101–250 people, reports on the AMEX exchange, and is pursuing a turnaround strategy following a sharp 81.19% 52-week decline in equity value.

Name

cbdMD

Legal name

cbdMD, Inc.

Website

https://cbdMD.com

Company type

Public

Founded year

2015

Operating status

Operating

Headcount range

51–100 employees

Short description

cbdMD is a publicly traded Charlotte, NC-based consumer wellness company that sells hemp-derived CBD and Delta 9 THC products — including gummies, softgels, tinctures, topicals, beverages, and pet products — through DTC e-commerce, wholesale, regional distributors, and a new Medicare clinical channel.

Ownership category

akta.pro rank

Product category

CBD and Hemp-Derived Wellness Consumer Products

NAICS

Food (Health) Supplement Retailers (456191), Medicinal and Botanical Manufacturing (325411), Health and Personal Care Retailers (456)

SIC

Medicinal Chemicals & Botanical Products (2833), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

CBD/Hemp Specialty Stores (Tinctures, Oils, Edibles) (CRANAHAA)

akta.pro secondary industries

CBD/Hemp Wellness & Supplements Retail (CRANAHAC), CBD/Hemp Topicals & Beauty Retail (CRANAHAB), Hemp-Derived Delta-8/Delta-9/THC-A Specialty Retail (Where Legal) (CRANAHAD), CBD/Hemp Pet Products Retail (CRANAHAF), Health & Wellness (Vitamins, Supplements, OTC) DTC (CRAFACAC), Hemp & CBD Product Wholesale Distribution (CRAOAIAG)

Keywords

• CBD wellness products
• Hemp-derived CBD
• THC beverages
• CBD gummies
• Broad spectrum CBD

Headquarters

HQ city

Charlotte

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Marketing or Sales, Personnel, Supply Chain, Technology or R&D

Revenue model

1. Direct-to-Consumer E-commerce: Online sales of CBD and THC products through cbdMD.com website, including one-time purchases and Subscribe & Save recurring revenue model with 25-35% subscriber discounts
2. Wholesale and Distribution: Bulk wholesale sales to retailers and distribution partners, including expansion of Herbal Oasis THC beverages through regional distributors
3. Clinical Healthcare Channel: Sales to physicians, health systems, and value-based care organizations participating in Medicare programs under CMS BEI pathway
4. Acquisition Integration - Bluebird Botanicals: Revenue streams expanded through Bluebird Botanicals brand acquisition including online CBD marketplace

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

cbdMD develops, manufactures/brands, and sells a portfolio of hemp-derived CBD and ancillary wellness products—including gummies, tinctures, softgels, topicals, pet products, Delta-9 THC products, and THC beverages—primarily through direct-to-consumer e-commerce with subscription, plus wholesale distribution, distributor partnerships, and a clinical healthcare channel serving Medicare-eligible patients.

Product overview

cbdMD is a leading CBD wellness brand offering a diversified portfolio of hemp-derived products across multiple delivery formats. The core product line includes broad spectrum and full spectrum CBD gummies, softgels/capsules, oil tinctures, and topicals with product categories for sleep, calm, focus, recovery, and relaxation benefits. The Delta 9 THC product line (YCBD) features nano-emulsified and micro-dose gummies, drink mixers, and the Herbal Oasis THC-infused social seltzer beverage brand. The company serves consumers seeking wellness products, retail partners through wholesale channels, and has recently launched a Clinical Healthcare Channel enabling Medicare-covered hemp-derived CBD access for physicians and health systems. The Bluebird Botanicals brand, acquired from Gaia Botanicals assets, expands the company's scientific platform and online marketplace. Key brand differentiators include GMP certification, independent lab testing, and published OECD-standard preclinical toxicology data supporting regulatory positioning.

Differentiator

Problem solved

Functional benefit

Brands

• Bluebird Botanicals: Acquired CBD brand including online CBD marketplace, trademarks, and related inventory.
• Herbal Oasis

Products and services

• cbdMD Gummies (Sleep, Calm, Focus, Immune, and Recovery formulations) Flavored broad-spectrum CBD gummy SKUs targeted at common daily wellness needs (sleep, calm/stress, focus, immune support, post-workout recovery); for adults buying direct online, via retail, or through the company's subscription program.
• cbdMD Tinctures/Oils Sublingual broad-spectrum and full-spectrum CBD tinctures sold in multiple strengths under the cbdMD brand; for individual consumers and wholesale partners seeking versatile, label-tested CBD formats.
• cbdMD Softgels Pre-measured broad-spectrum or full-spectrum CBD softgels for consistent daily dosing in a familiar supplement form; target individual consumers and the subscription channel.
• cbdMD Topicals (creams, balms, roll-ons) Topical CBD creams, balms, and roll-ons positioned for targeted application (muscle recovery, joint comfort, skin); sold through DTC and retail partners to adult consumers seeking non-ingestible options.
• cbdMD Pet CBD Products CBD oils/tinctures and treats formulated for pets; sold through the cbdMD DTC site for pet owners and through select retail accounts.
• Delta-9 THC Products Adult-use Delta-9 THC ingestibles, topicals, and SKUs compliant with federal hemp-derived THC thresholds; sold to individual consumers through the company's online channels and partner retailers where state regulation permits.
• Herbal Oasis THC Beverages Herbal Oasis brand of hemp-derived THC-infused beverages; for adult consumers seeking a low-calorie, format-differentiated alternative to gummies and tinctures.
• Bluebird Botanicals brand of CBD wellness products Bluebird Botanicals brand product line (gummies, tinctures, softgels, and topicals) positioned at a different price point and audience from cbdMD; sold through DTC and wholesale within the company's brand portfolio.
• Subscribe & Save Subscription Program Recurring home delivery subscription of cbdMD products through the direct-to-consumer site, offering discounted pricing and predictable replenishment for repeat users.
• Wholesale and Distributor Program Wholesale and distributor partnership program enabling retail accounts, pharmacies, and natural-product stores to purchase cbdMD, Bluebird Botanicals, and Herbal Oasis SKUs for on-shelf sale in U.S. markets where legal.
• Clinical Healthcare Channel Product Line (GRAS CBD Isolate) CBD isolate SKU registered as a self-affirmed Generally Recognized As Safe (GRAS) ingredient with supporting OECD-compliant toxicology data and an FDA submission; routed via the company's clinical healthcare channel to eligible Medicare populations and partner healthcare providers.

Quantifiable outcome

• 12% sequential revenue growth in Q1 FY2026 following Bluebird Botanicals acquisition
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered minor and core.

• Cherry Bekaert LLPminorOthers · 30 March 2026Ratified as company's auditor at 2026 Annual Meeting of Shareholders.
• Morales Beverage GroupcoreChannel Partner/ Reseller/ Distributor · 2 February 2026Regional distribution partnership for Herbal Oasis THC-infused social seltzer brand. cbdMD's functional beverage brand expands into Louisiana market through Morales Beverage Group, targeting consumers seeking modern alcohol alternatives. Collaboration includes shipping starting late February 2026 following early success in Texas market, extending regional footprint across Gulf South.
• Gaia Botanicals, LLCcoreStrategic or Co-development Partner · 12 January 2026Asset Purchase Agreement to acquire substantially all assets of Gaia Botanicals including Bluebird Botanicals brand, online CBD marketplace, related trademarks, and inventory. Transaction valued at 425,000 restricted common shares at closing plus up to 525,000 earnout shares. Includes assumption of certain liabilities. All-equity transaction expanding revenue streams, IP, and regulatory assets.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Lazarus Naturals: Vertically integrated CBD brand selling tinctures, capsules, topicals, and pet products DTC with strong value positioning and assistance programs. Comparable to cbdMD on hemp-derived product breadth and direct-to-consumer focus.
• Charlotte's Web Holdings: Publicly traded CBD wellness brand selling tinctures, gummies, capsules, and topicals through DTC e-commerce and wholesale channels. Directly comparable to cbdMD on product mix, distribution model, and target consumer segments.
• Green Roads: CBD wellness brand founded by pharmacists, selling gummies, oils, topicals, and pet products through DTC and retail/wholesale. Comparable to cbdMD on product mix, regulatory positioning, and pharmacist-led credibility.
• CV Sciences (PlusCBD Oil): Publicly traded company focused on hemp-derived CBD consumer products (PlusCBD Oil brand) across retail and DTC. Similar science-led positioning with published clinical research on hemp extracts and comparable regulatory strategy.
• Medterra CBD: DTC CBD brand offering tinctures, gummies, topicals, and pet products through e-commerce and wholesale. Closely comparable to cbdMD on product portfolio, pricing, and target wellness consumer.

Broad incumbents

• Cronos Group: Cannabis consumer products company with hemp-derived CBD offerings under brands like Spinach and Lord Jones. Comparable to cbdMD as a broader incumbent operating in adjacent consumer cannabinoid categories.
• Canopy Growth: Global cannabis leader with CBD wellness products and beverage initiatives. Comparable to cbdMD as a broader incumbent with overlapping CBD consumer products and strategic interest in THC-infused beverages.
• Curaleaf Holdings: Multi-state cannabis operator with a Select CBD/hemp product line sold through dispensaries and retail. Comparable to cbdMD as a broader incumbent in hemp-derived cannabinoids with deep distribution infrastructure.
• Irwin Naturals: Established herbal supplement brand expanding into hemp-derived CBD products across broad retail distribution. Comparable to cbdMD as a broader incumbent moving into the same hemp-CBD category with deeper retail relationships.
• Tilray Brands: Large Canadian cannabis company with broad hemp and CBD product portfolio across North America. Comparable to cbdMD as a broader incumbent operating in the same hemp-derived CBD retail space with significantly larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/cbdmd
• Instagraminstagram.com/cbdmd.usa
• Xx.com/cbdmd_usa
• Facebookfacebook.com/cbdmd.usa

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about cbdMD